Autres langues Fulgent Genetics, Inc.

Actions

FLGT

US3596641098

Temps réel estimé Cboe BZX Autres places de cotation 19:09:39 10/06/2024			Varia. 5j.	Varia. 1 janv.
19,96 ^USD	-1,65 %		-4,15 %	-30,80 %

03/05	Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024
03/05	Fulgent Genetics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer	03/06
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting	24/05
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics	14/05
Fulgent Reports First Quarter 2024 Financial Results	06/05
Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M	03/05
Fulgent Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05
Fulgent Reports First Quarter 2024 Financial Results	03/05
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Year 2024	03/05
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024	11/04
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	28/02
Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024	28/02
Fulgent Genetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results	28/02
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 Revenue $70.5M	28/02
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 EPS $0.28	28/02
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024	13/02
Cooper Unit, Fulgent Genetic to Offer Newborn Genetic Screening Panels	09/02
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing	09/02
Cord Blood Registry by CooperSurgical, Inc. and Fulgent Genetics, Inc. Launch Innovative Genetic Testing	09/02
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Fulgent Genetics, Inc.

Actions

FLGT

US3596641098

Autres langues

Filtres